Dr Mostafa - Working in the lab_16-9

Fund local research

Your donations provide vital funding for research.

Cancer Council Queensland is committed to ensuring no Queenslander has to go through cancer alone. We are also committed to investing in lifesaving, local cancer research to prevent and treat cancers more effectively.

Your generous donations help us fund the brightest minds in cancer research. By working together, we can fund local research to make global breakthroughs. We make this possible by directly funding early career cancer researchers who are on the front-line of clinical innovations in cancer detection and treatment.

This page covers
Your donation makes a real impact

Contributions go towards world-class research, prevention programs and support service.

The Next Gen Research Fellowship

The Cancer Council Queensland Next Gen Research Fellowships replace our Accelerating Collaborative Cancer Research grants scheme and are focused on funding early career cancer researchers who are on the front-line of clinical innovations and breakthroughs in cancer detection and treatment.

Meet the 2024 Next Gen Cancer Research Fellowship recipients

Our inspiring grant recipients are creating hope and innovating in a way that could change the future for a number of people with cancer. Here are the doctors at the front line of cancer research.

Dr Mostafa Kamal Masud

Dr Masud from The University of Queensland is conducting cancer research focused on developing a device which, using nanoengineered structures, aims to make it possible to detect early-stage ovarian cancer within two hours at a GP clinic.

Dr Jasmin Straube

Dr Jasmin Straube from QIMR Berghofer is researching vulnerabilities in leukemic stem cells carrying poor prognostic mutations. Her work will play a critical role in improving outcomes for patients with myeloid blood cancer.

Dr Mathias Seviiri

Dr Mathias Seviiri, also from QIMR Berghofer, is tackling the complex landscape of skin cancer. His research aims to unravel the complex relationships between genetics, treatment responses, and adverse events in patients undergoing treatment for melanoma and keratinocyte cancers.

When you donate to fund cancer research, you invest in a brighter future for Queenslanders with cancer

In addition to making the next big breakthrough possible, your contribution will also be recognised with:

  • Exclusive co-branding and naming rights for one of four fellowships awarded each year.
  • Promotional and PR opportunities as the research activity progresses.
  • Ongoing exclusive research updates directly from the research team you’re funding.

Ready to fund important cancer research? Talk to us.

Both businesses and individuals are welcome to enquire.

Your cancer research donations in action

Some of our recently awarded grants have helped fund:

  • A University of Queensland cancer research project looking at oesophageal cancer, a disease that currently has very few therapeutic options. The project, running until 2026, will undertake a complex assessment of PET/CT scans and pathology slides, using deep learning computational methods to identify new image markers reflective of the tumour profile. Researchers then aim to develop a risk prediction model that complements current patient diagnostics and provides improved precision medicine.
  • A University of Queensland cancer research project that will undertake the world’s first clinical trial of a central line lock that may prevent complications such as infections, blood clots and line blockage for children with cancer. Find out more.
  • A University of Queensland cancer research project which consists of the first ever implementation research of the feasibility and effectiveness of CT screening (in conjunction with smoking cessation), for detecting curable lung cancers in Australian Aboriginal and Torres Strait Islander communities. Find out more.
  • A Griffith University clinical trial designed to determine the effects of an exercise intervention during first-line chemotherapy on survival from ovarian cancer. Find out more.